Cited by 637Psychedelics and Drug StudiesParanormal Experiences and BeliefsReligion, Spirituality, and Psychology

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Open access

Barrett, Frederick S, Johnson, Matthew W, Griffiths, Roland R·2015·Journal of Psychopharmacology

DOI 10.1177/0269881115609019PMC PMC5203697

Open this paper in CoChat — free account

Abstract

The 30-item revised Mystical Experience Questionnaire (MEQ30) was previously developed within an online survey of mystical-type experiences occasioned by psilocybin-containing mushrooms. The rated experiences occurred on average eight years before completion of the questionnaire. The current paper validates the MEQ30 using data from experimental studies with controlled doses of psilocybin. Data were pooled and analyzed from five laboratory experiments in which participants ( n=184) received a moderate to high oral dose of psilocybin (at least 20 mg/70 kg). Results of confirmatory factor analysis demonstrate the reliability and internal validity of the MEQ30. Structural equation models demonstrate the external and convergent validity of the MEQ30 by showing that latent variable scores on the MEQ30 positively predict persisting change in attitudes, behavior, and well-being attributed to experiences with psilocybin while controlling for the contribution of the participant-rated intensity of drug effects. These findings support the use of the MEQ30 as an efficient measure of individual mystical experiences. A method to score a “complete mystical experience” that was used in previous versions of the mystical experience questionnaire is validated in the MEQ30, and a stand-alone version of the MEQ30 is provided for use in future research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1177/0269881115609019

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives
Hu, L., & Bentler, P. M. (1999) · Structural Equation Modeling A Multidisciplinary Journal · doi:10.1080/10705519909540118 · Cited by 108,788
lavaan : An R Package for Structural Equation Modeling
Rosseel, Y. (2012) · Journal of Statistical Software · doi:10.18637/jss.v048.i02 · Cited by 27,955
Alternative Ways of Assessing Model Fit
Browne, M. W., & Cudeck, R. (1992) · Sociological Methods & Research · doi:10.1177/0049124192021002005 · Cited by 27,200
Confirmatory factor analysis for applied research
Brown, T. A. (2007) · Choice Reviews Online · doi:10.5860/choice.44-2769 · Cited by 15,621
Testing Structural Equation Models.
Mueller, C. W., Bollen, K. A., & Long, J. S. (1994) · Contemporary Sociology A Journal of Reviews · doi:10.2307/2074955 · Cited by 14,211
EQS : structural equations program manual
Bentler, P. M. (1989) · Medical Entomology and Zoology · Cited by 9,669
Detection Theory: A User's Guide
Macmillan, N. A., & Creelman, C. D. (1991) · Cited by 5,415
A scaled difference chi-square test statistic for moment structure analysis
Satorra, A., & Bentler, P. M. (2001) · Psychometrika · doi:10.1007/bf02296192 · Cited by 5,282
The varieties of religious experience: A study in human nature.
James, W. (1902) · doi:10.1037/10004-000 · Cited by 5,204

Show all 34 references

Research works printed but not linked: 3

Pahnke WN, 1963, Drugs and Mysticism: An Analysis of the Relationship Between Psychedelic Drugs and the Mystical Consciousness
Pahnke WN, 1967, LSD Man & Society, 60
Richards WA, 1975, Counseling, Peak Experiences and the Human Encounter with Death: An Empirical Study of the Efficacy of DPT-Assitance Counseling in Enhancing Quality of Life of Persons with Terminal Cancer and Their Closest Family Members

Sorted by citations

Items 201–300 of 635

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
de la Salle, S., Kettner, H., Lévesque, J. T., Garel, N., Dames, S., Patchett-Marble, R., Rej, S., Gloeckler, S. G., Erritzøe, D., Carhart-Harris, R. L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-66817-0 · Cited by 22
Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use
Hübner, S., Haijen, E. C. H. M., Kaelen, M., Carhart-Harris, R. L., & Kettner, H. (2021) · Journal of Medical Internet Research · doi:10.2196/25973 · Cited by 20
Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting
Tagliazucchi, E., Zamberlán, F., Cavanna, F., de la Fuente, L., Romero, C., Perl, Y. S., & Pallavicini, C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.720066 · Cited by 27
Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study
Family, N., Hendricks, P. S., Williams, L. T. J., Luke, D. P., Maillet, É. L., Maillet, É. L., & Raz, S. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069103 · Cited by 23
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland
Kangaslampi, S., Hausen, A., & Rauteenmaa, T. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1767321 · Cited by 31
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
Aday, J. S., McAfee, J., Conroy, D. A., Hosanagar, A., Tarnal, V., Weston, C. L., Scott, K., Horowitz, D., Geller, J. A., Harte, S. E., et al. (2025) · Frontiers in Pain Research · doi:10.3389/fpain.2025.1527783 · Cited by 22
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodríguez, C. I., Kalin, N. H., & McDonald, W. M. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19104 · Cited by 28
Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials
Herrmann, Z. M., Earleywine, M., Leo, J. A. D., Slabaugh, S., Kenny, T., & Rush, A. J. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2125467 · Cited by 21
Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
Jensen, M. E., Stenbæk, D. S., Juul, T. S., Fisher, P. M., Ekstrøm, C. T., Knudsen, G. M., & Fink‐Jensen, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-066019 · Cited by 25
The psychedelic effects of cannabis: A review of the literature
Wolinsky, D., Barrett, F. S., & Vandrey, R. G. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231209194 · Cited by 26
Self-citation
Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants
Straumann, I., Avedisian, I., Klaiber, A., Varghese, N., Eckert, A., Rudin, D., Luethi, D., & Liechti, M. E. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01972-6 · Cited by 21
Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants
Vizeli, P., Studerus, E., Holze, F., Schmid, Y., Dolder, P. C., Ley, L., Straumann, I., Becker, A., Müller, F., Arikci, D., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03074-9 · Cited by 25
Take a deep breath: Benefits of neuroplasticity practices for software developers and computer workers in a family of experiments
Penzenstadler, B., Torkar, R., & Montes, C. M. (2022) · Empirical Software Engineering · doi:10.1007/s10664-022-10148-z · Cited by 27
Reduced death anxiety and obsessive beliefs as mediators of the therapeutic effects of psychedelics on obsessive compulsive disorder symptomology
Moreton, S. G., Burden-Hill, A., & Menzies, R. E. (2022) · Clinical Psychologist · doi:10.1080/13284207.2022.2086793 · Cited by 19
Reduced death anxiety as a mediator of the relationship between acute subjective effects of psychedelics and improved subjective well-being
Moreton, S. G., Arena, A. F. A., Foy, Y., & Menzies, R. E. (2023) · Death Studies · doi:10.1080/07481187.2023.2169848 · Cited by 21
Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective
Meling, D., & Scheidegger, M. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1100058 · Cited by 22
Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being
Bonnelle, V., Feilding, A., Rosas, F. E., Nutt, D. J., Carhart-Harris, R. L., & Timmermann, C. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241276788 · Cited by 24
Nonordinary Experiences, Well-being and Mental Health: A Systematic Review of the Evidence and Recommendations for Future Research
Maraldi, E. D. O., Taves, A., Moll, J., Hartle, L., Moreira‐de‐Oliveira, M. E., Bortolini, T., & Fischer, R. D. (2023) · Journal of Religion and Health · doi:10.1007/s10943-023-01875-8 · Cited by 23
Classification schemes of altered states of consciousness
Fort, L. D., Costines, C., Wittmann, M., Athena Demertzi, A., & Schmidt, T. T. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106178 · Cited by 31
Psychedelic Epistemology: William James and the “Noetic Quality” of Mystical Experience
Cole‐Turner, R. (2021) · Religions · doi:10.3390/rel12121058 · Cited by 19
Insular Stimulation Produces Mental Clarity and Bliss
Nencha, U., Spinelli, L., Vulliémoz, S., Seeck, M., & Picard, F. (2021) · Annals of Neurology · doi:10.1002/ana.26282 · Cited by 19
Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey
Kervadec, E., Fauvel, B., Strika-Bruneau, L., Amirouche, A., Verroust, V., Piolino, P., Roméo, B., & Benyamina, A. (2023) · Alcohol and Alcoholism · doi:10.1093/alcalc/agad078 · Cited by 22
Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study
Nayak, S. M., White, S. H., Hilbert, S. N., Lowe, M. X., Jackson, H., Griffiths, R. R., Garcia‐Romeu, A., & Yaden, D. B. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2346130 · Cited by 22
Self-citation
Effects of Psychedelics in Older Adults: A Prospective Cohort Study
Kettner, H., Roseman, L., Gazzaley, A. H., Carhart-Harris, R. L., & Pasquini, L. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.05.007 · Cited by 19
Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)
Dworatzyk, K., Jansen, T., & Schmidt, T. T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264927 · Cited by 19
Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response
Calder, A. E., Rausch, B., Liechti, M. E., Holze, F., & Hasler, G. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241278873 · Cited by 20
““Complete” mystical experiences were defined as a score of > 60% of the total possible score on all four subscales of the MEQ30 (Barrett et al., 2015).”
BackgroundInfluential
Psychedelic risks and benefits: A cross-sectional survey study
Goldy, S. P., Du, B. A., Rohde, J. S., Nayak, S. M., Strickland, J. C., Ehrenkranz, R. C., Levine, M., Barrett, F. S., & Yaden, D. B. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241292951 · Cited by 18
Self-citation
Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation
Barrett, F. S., Zhou, Y., Carbonaro, T. M., Roberts, J., Smith, G. S., Griffiths, R. R., & Wong, D. F. (2022) · Frontiers in Neuroergonomics · doi:10.3389/fnrgo.2021.784576 · Cited by 20
Self-citation
Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences
Rieser, N. M., Gubser, L. P., Moujaes, F., Duerler, P., Lewis, C. R., Michels, L., Vollenweider, F. X., & Preller, K. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-44153-z · Cited by 19
Understanding the Nature of Oneness Experience in Meditators Using Collective Intelligence Methods
Lente, E. V., & Hogan, M. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.02092 · Cited by 18
Validation of the imperial psychedelic predictor scale
Angyus, M., Osborn, S., Haijen, E. C. H. M., Erritzøe, D., Peill, J. M., Lyons, T., Kettner, H., & Carhart-Harris, R. L. (2024) · Psychological Medicine · doi:10.1017/s0033291724002204 · Cited by 20
Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
Estric, C., Duron, T., Kabani, S., & López‐Castromán, J. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251338214 · Cited by 18
The Occurrence of Psychologically Profound, Meaningful, and Mystical Experiences During a Month-Long Meditation Retreat
Zanesco, A. P., King, B. G., Conklin, Q. A., & Saron, C. D. (2023) · Mindfulness · doi:10.1007/s12671-023-02076-w · Cited by 18
Classic Psychedelic Use and Current Meditation Practice
Simonsson, C., Chambers, R., Hendricks, P. S., Goldberg, S. B., Osika, W., Schlosser, M., Ryde, A., Christersson, E., & Simonsson, O. (2023) · Mindfulness · doi:10.1007/s12671-023-02103-w · Cited by 20
Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey
Roméo, B., Fauvel, B., Dejean, S., Strika-Bruneau, L., Amirouche, A., Verroust, V., Piolino, P., & Benyamina, A. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2227171 · Cited by 17
‘Mind-Revealing’ Psychedelic States: Psychological Processes in Subjective Experiences That Drive Positive Change
Walther, R. F. E., & van Schie, H. T. (2024) · Psychoactives · doi:10.3390/psychoactives3030026 · Cited by 20
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat
Meling, D., Egger, K., Aicher, H., Redondo, J. J., Mueller, J., Dornbierer, J., Temperli, E., Vasella, E. A., Caflisch, L., Pfeiffer, D., et al. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241282637 · Cited by 20
Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome
Dahan, J. D. C., Dadiomov, D., Bostoen, T., & Dahan, A. (2024) · npj Mental Health Research · doi:10.1038/s44184-024-00091-w · Cited by 18
Neural and subjective effects of inhaled DMT in natural settingsPreprint
Pallavicini, C., Cavanna, F., Zamberlán, F., de la Fuente, L. A., Perl, Y. S., Arias, M., Romero, C., Carhart-Harris, R. L., Timmermann, C., & Tagliazucchi, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.19.258145 · Cited by 17
Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users
Fauvel, B., Kangaslampi, S., Strika-Bruneau, L., Roméo, B., & Piolino, P. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2059796 · Cited by 36
GH001 vs Placebo in Patients With Treatment-Resistant Depression
Cubała, W. J., Bajbouj, M., Bauer, M., Baune, B. T., Cardoner, N., Devlin, F., Doolin, K., Herrero, R. D., Elices, M., Feeney, A., et al. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.0096 · Cited by 18
Psychedelics and environmental virtues
Kirkham, N., & Letheby, C. (2022) · Philosophical Psychology · doi:10.1080/09515089.2022.2057290 · Cited by 20
Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing
Qiu, T. T., & Minda, J. P. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2060773 · Cited by 15
Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants
Robison, R., Brendle, M., Moore, C., Cross, H. L., Helm, L., Darling, S., Thayer, S. D., Thielking, P., & Shannon, S. M. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2186285 · Cited by 17
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study
Aday, J. S., Bloesch, E. K., Davis, A. K., Domoff, S. E., Scherr, K. C., Woolley, J. D., & Davoli, C. C. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2312980 · Cited by 18
Investigating the relationship between changes in metaphysical beliefs and death anxiety following a significant psychedelic experience
Moreton, S. G., Barr, N. N. T., & Giese, K. J. (2024) · Death Studies · doi:10.1080/07481187.2024.2352726 · Cited by 17
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants
Erne, L., Vogt, S. B., Müller, L., Nuraj, A., Becker, A., Klaiber, A., Zuparic, M., Varghese, N., Eckert, A., Rudin, D., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-02041-8 · Cited by 17
Psilocybin: From Psychiatric Pariah to Perceived Panacea
Fonzo, G. A., Wolfgang, A. S., Barksdale, B. R., Krystal, J. H., Carpenter, L. L., Kraguljac, N. V., Grzenda, A. L., McDonald, W. M., Widge, A. S., Rodríguez, C. I., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230682 · Cited by 20
Examining the therapeutic effect of ceremonial ayahuasca on narcissistic personality and antagonistic externalizing in adults
Weiss, B., Sleep, C., Miller, J. D., & Campbell, W. K. (2023) · Journal of Personality Disorders · doi:10.1521/pedi.2023.37.2.131 · Cited by 15
Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology
Kelly, D. F., Heinzerling, K. G., Sharma, A., Gowrinathan, S., Sergi, K., & Mallari, R. J. (2022) · Neurosurgery · doi:10.1227/neu.0000000000002275 · Cited by 16
Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial
Becker, A., Humbert‐Droz, M., Mueller, L., Jelušić, A., Tolev, A., Straumann, I., Avedisian, I., Erne, L., Thomann, J., Luethi, D., et al. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3618 · Cited by 16
Psychedelics align brain activity with context
Stoliker, D., Novelli, L., Khajehnejad, M. A., Biabani, M., Greaves, M. D., Barta, T., Williams, M., Chopra, S., Bazin, O., Simonsson, O., et al. (2026) · Nature · doi:10.1038/s41586-026-10910-z · Cited by 18
Self-citation
Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions
Griffiths, R. R., Jesse, R., Richards, W. A., Johnson, M. W., Sepeda, N. D., Bossis, A. P., & Ross, S. (2025) · Psychedelic Medicine · doi:10.1089/psymed.2023.0044 · Cited by 17
Self-citation
Refining the biopsychosocial model for musculoskeletal practice by introducing religion and spirituality dimensions into the clinical scenario
Zegarra-Parodi, R., Draper‐Rodi, J., & Cerritelli, F. (2019) · International journal of osteopathic medicine · doi:10.1016/j.ijosm.2019.04.001 · Cited by 15
Untitled work
Barnett (2024) · doi:10.1089/psymed.2023.0010 · Cited by 13
Self-citation
Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial
Lewis, B. R., Hendrick, J., Byrne, K., Odette, M. M., Wu, C., & Garland, E. L. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004519 · Cited by 19
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework
van den Berg, M., Magaraggia, I., Schreiber, R., Hillhouse, T. M., & Porter, J. H. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06106-8 · Cited by 13
Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment
David, J., Bouso, J. C., Kohek, M., Oña, G., Tadmor, N., Arnon, T., Dor‐Ziderman, Y., & Berkovich‐Ohana, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1287961 · Cited by 12
The Setting Questionnaire for the Ayahuasca Experience: Questionnaire Development and Internal Structure
Pontual, A. A. D. D., Tófoli, L. F., Collares, C. F., Ramaekers, J. G., & Corradi-Webster, C. M. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.679016 · Cited by 15
Psychedelic Resting-state Neuroimaging: A Review and Perspective on Balancing Replication and Novel Analyses.Preprint
McCulloch, D., Knudsen, G., Barrett, F., Doss, M. K., Carhart-Harris, R. L., Rosas, F., Deco, G., Kringelbach, M., Preller, K., Ramaekers, J., et al. (2021) · Neuroscience and Biobehavioral Reviews · doi:10.31234/osf.io/64kyg · Cited by 106
Self-citation
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial
Erritzøe, D., Barba, T., Benway, T. A., Joel, Z., Good, M., Layzell, M., Baker-Jones, M., Campbell, G., Murphy-Beiner, A., Rands, P., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04154-z · Cited by 15
Entheogenic Spirituality: Characteristics of Spiritually Motivated Psychedelics Use
Johnstad, P. G. (2022) · International Journal for the Psychology of Religion · doi:10.1080/10508619.2022.2148060 · Cited by 15
Clarifying and measuring the characteristics of experiences that involve a loss of self or a dissolution of its boundaries
Canby, N. K., Lindahl, J. R., Britton, W. B., & Córdova, J. V. (2024) · Consciousness and Cognition · doi:10.1016/j.concog.2024.103655 · Cited by 18
Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties
Atiq, M. A., Baker, M. R., Voort, J. L. V., Vargas, M. V., & Choi, D. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06599-5 · Cited by 16
Endorsement of metaphysical idealism mediates a link between past use of psychedelics and wellbeing
Jylkkä, J., Krabbe, A., & Jern, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-63687-4 · Cited by 15
5-Methoxy-N,N-dimethyltryptamine: An Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity
Germann, C. B. (2019) · Activitas Nervosa Superior · doi:10.1007/s41470-019-00063-y · Cited by 14
A potential role for psilocybin in the treatment of obsessive-compulsive disorder
Jacobs, E. (2020) · Journal of Psychedelic Studies · doi:10.1556/2054.2020.00128 · Cited by 17
The Relationship Between Psychedelic Use, Mystical Experiences, and Pro-Environmental Behaviors
Paterniti, K., Bright, S. J., & Gringart, E. (2022) · Journal of Humanistic Psychology · doi:10.1177/00221678221111024 · Cited by 15
Human behavioral pharmacology of psychedelics
Strickland, J. C., & Johnson, M. W. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.003 · Cited by 16
Self-citation
Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts
Graziosi, M., Singh, M., Nayak, S. M., & Yaden, D. B. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2255274 · Cited by 15
Psychometric brahman , psychedelic science: Walter Stace, transnational Vedanta, and the Mystical Experience Questionnaire
Breau, J. A., & Gillis‐Smith, P. (2023) · Interdisciplinary Science Reviews · doi:10.1080/03080188.2023.2266322 · Cited by 16
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects
McCulloch, D. E.-W., Liechti, M. E., Kuypers, K. P. C., Nutt, D., Lundberg, J., Stenbæk, D. S., Goodwin, G. M., Gründer, G., Butlen‐Ducuing, F., Haberkamp, M., et al. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.103938 · Cited by 14
Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy
Schmid, Y., & Bershad, A. K. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.02.001 · Cited by 15
Psychedelic use and psychological flexibility: The role of meaningful intention and decentering
Campo, W. M., & Yali, A. M. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00350 · Cited by 12
Acceptance as a possible link between past psychedelic experiences and psychological flexibility
Krabbe, A., Sikka, P., & Jylkkä, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-75595-8 · Cited by 15
Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study
Jones, G. M., Lowe, M. X., Nayak, S. M., Sepeda, N. D., Kettner, H., Carhart-Harris, R. L., Jackson, H., & Garcia‐Romeu, A. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.058 · Cited by 12
States of Consciousness, the qEEG, and Noetic Snapshots of the Brain/Mind Interface: A Case Study of Hypnosis and Sidhi Meditation
Pekala, R. J., & Creegan, K. (2020) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2002019 · Cited by 13
Acute and subacute psychoactive effects of Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): retrospective reports
Schmidt, T. T., Reiche, S., Hage, C. L. C., Bermpohl, F., & Majić, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-78527-4 · Cited by 12
The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol
Johansen, L., Liknaitzky, P., Nedeljkovic, M., Mastin-Purcell, L., & Murray, G. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01930-7 · Cited by 11
Investigating the associations of acute psychedelic experiences and changes in racial trauma symptoms, psychological flexibility, and substance use among People with Racial and Ethnic Minoritized Identities in the United States and Canada
Haeny, A. M., Lopez, J., Grigas, P. A. C., Crouch, M. C., Davis, A. K., & Williams, M. T. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209035 · Cited by 11
Phytochemical interventions for post-traumatic stress disorder: A cluster co-occurrence network analysis using CiteSpace
Gao, B., Qu, Y.-C., Cai, M., Zhang, Y.-Y., Lu, H., Li, H.-X., Tang, Y., & Shen, H. (2023) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2023.06.006 · Cited by 12
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use
Mathai, D. S., Roberts, D. E., Nayak, S. M., Sepeda, N. D., Lehrner, A. L., Johnson, M. W., Lowe, M. X., Jackson, H., & Garcia‐Romeu, A. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2461997 · Cited by 14
Self-citation
Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada”
Fagetti, A., & Mercadillo, R. E. (2022) · Anthropology of Consciousness · doi:10.1111/anoc.12163 · Cited by 12
Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches
Batievsky, D., Weiner, M. D., Kaplan, S. B., Thase, M. E., Maglione, D. N., & Vidot, D. C. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.1127863 · Cited by 11
Enriching the Common Core of Mystical Experience: A Qualitative Analysis of Interviews with Daoist Monks and Nuns
Chen, Z. J., Guo, S., & Cowden, R. G. (2023) · International Journal for the Psychology of Religion · doi:10.1080/10508619.2023.2265267 · Cited by 10
Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees
Lowe, M. X., Kettner, H., Jolly, D. R. P., Carhart-Harris, R. L., & Jackson, H. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1279887 · Cited by 14
Comforting delusions? How to evaluate the plausibility of mystical-type insights in psychedelic experiences
Jylkkä, J. (2024) · Philosophical Psychology · doi:10.1080/09515089.2024.2391433 · Cited by 10
Fire Kasina advanced meditation produces experiences comparable to psychedelic and near-death experiences: A pilot study
Woollacott, M. H., Riddle, J., Hermansson, N., Sacchet, M. D., & Ingram, D. M. (2024) · EXPLORE · doi:10.1016/j.explore.2024.103056 · Cited by 11
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
Yaden, D. B., Graziosi, M., Owen, A. M., Agin-Liebes, G., Aaronson, S. T., Allen, K. E., Barrett, F. S., Bogenschutz, M. P., Carhart-Harris, R. L., Ching, T. H. W., et al. (2025) · Psychedelic Medicine · doi:10.1089/psymed.2024.0019 · Cited by 12
Self-citation
The ketamine chameleon: history, pharmacology, and the contested value of experience
Diep, D., de la Salle, S., Lévesque, J. T., Lifshitz, M., Garel, N., & Greenway, K. T. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2459377 · Cited by 10
The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression
Greenway, K. T., Garel, N., Dinh-Williams, L.-A., Lévesque, J. T., Kaelen, M., Dagenais‐Beaulé, V., de la Salle, S., Erritzøe, D., Looper, K. J., Turecki, G., et al. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.102 · Cited by 12
Cultivation, chemistry, and genome of Psilocybe zapotecorum
Miller, D. R., Jacobs, J., Rockefeller, A., Singer, H., B., I. M., Conway, J., Slot, J. C., & Cliffel, D. E. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00332 · Cited by 12
A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes
Pilecki, B. C., Luoma, J. B., & Lear, K. M. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00295 · Cited by 12
Dr. A.M. - A Case of a Modern Mystic? Implications for Psychology and Medicine
Facco, E., Lucangeli, D., & Tressoldi, P. E. (2018) · Spirituality in Clinical Practice · doi:10.1037/scp0000171 · Cited by 10
The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016
Barrett, F. S., & Griffiths, R. R. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2564 · Cited by 11
Self-citation
A novel model of divergent predictive perception
Reeder, R., Sala, G., & van Leeuwen, T. M. (2024) · Neuroscience of Consciousness · doi:10.1093/nc/niae006 · Cited by 11
Perceived attachment history predicts psychedelic experiences: A naturalistic study
Cherniak, A. D., Mikulincer, M., Brulin, J. G., & Granqvist, P. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00330 · Cited by 10
Considering distinct positive emotions in psychedelic science
Goldy, S. P., Hendricks, P. S., Keltner, D. J., & Yaden, D. B. (2024) · International Review of Psychiatry · doi:10.1080/09540261.2024.2394221 · Cited by 9
Psychoactive substances for the treatment of neuropsychiatric disorders
Zhen, Z., Sun, X., Yuan, S., & Zhang, J. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104193 · Cited by 11
Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey
Stroud, J., Rice, C., Orsini, A., Schlosser, M., Lee, J., Mandy, W., & Kamboj, S. K. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06685-8 · Cited by 11

Authors: Barrett, F. S., Johnson, M. W., & Griffiths, R. R.
Affiliations: Johns Hopkins University (US)
Corresponding author: Barrett, Frederick S
ORCID: Barrett, Frederick S
Johnson, Matthew W
Griffiths, Roland R
Venue: Journal of Psychopharmacology
Publisher: SAGE Publications
Published: 2015-10-06
Volume: 29
Issue: 11
Pages: 1182-1190
ISSN: 0269-8811 (ISSN-L)
1461-7285
DOI: 10.1177/0269881115609019
PMC: PMC5203697
OpenAlex: W2340085151
Cited by: 637
References: 34
Citations by year: 2026: 91 · 2025: 110 · 2024: 123 · 2023: 78 · 2022: 78 · 2021: 53 · 2020: 38 · 2019: 12 · 2018: 20 · 2017: 21 · 2016: 12
FWCI: 21.94
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Journal of Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (R01DA003889, T32DA007209, R01DA03889)
Topics: Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
Social Sciences › Health › Religion, Spirituality, and Psychology
Keywords: psilocybin, mystical experience, psychedelic drug effects, questionnaire validation, factor structure, convergent validity, attitude change, well-being
MeSH terms: Administration, Oral, Hallucinogens, Humans, Mysticism, Psilocybin, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks